Anika Therapeutics | ANIK - Marktkapitalisierung

Aktienkurs
14.76
Täglich Wechseln
-0.46 -3.02%
Monatlich
2.79%
Jährlich
8.21%
Q2 Prognose
14.36




Marktkapitalisierung Veränderung Datum
Abbott USD 217.86B 15.25B 2025-12
Agenus USD 107M 16M 2025-12
Agios Pharmaceuticals USD 1.59B 745M 2025-12
Anika Therapeutics USD 139M 3M 2025-12
Arrowhead Research USD 9.02B 4.25B 2025-12
Enanta Pharmaceuticals USD 122M 98M 2024-12
Halozyme Therapeutics USD 7.91B 664M 2025-12
Heron Therapeutics USD 238M 7M 2025-12
Insmed USD 37.12B 6.68B 2025-12
Integra LifeSciences USD 967M 150M 2025-12
J&J USD 500.24B 67.44B 2025-12
Karyopharm Therapeutics USD 652M 517M 2026-04
MacroGenics USD 102M 4M 2025-12
Merit Medical Systems USD 5.23B 297M 2025-12
Sanofi EUR 100.88B 4.46B 2025-12
Smith & Nephew USD 3.77B 9.55B 2026-04
Stryker USD 134.41B 6.92B 2025-12
Veracyte USD 3.33B 627M 2025-12
Xencor USD 1.09B 256M 2025-12
Zimmer Biomet Holdings USD 17.82B 1.69B 2025-12